The neonatal phototherapy devices market plays a crucial role in managing neonatal jaundice, a condition that affects a large percentage of newborns globally. According to Persistence Market Research, the global market is expected to grow from US$ 110.4 Mn in 2025 to US$ 147.9 Mn by 2032, registering a CAGR of 4.3%. This steady expansion is fueled by the rising incidence of preterm births and neonatal jaundice, which require timely intervention to prevent complications such as kernicterus and neurodevelopmental issues.
Among product types, phototherapy lamps dominate with nearly 48.6% share due to their proven effectiveness in hospitals and NICUs. Regionally, North America leads the market, holding 40.2% share by 2025, thanks to its advanced healthcare infrastructure, high awareness about neonatal care, and rapid adoption of LED-based phototherapy systems. Meanwhile, Asia Pacific and East Asia are emerging as high-potential regions, driven by government investments, expanding healthcare infrastructure, and rising birth rates.
Key Highlights from the Report:
• The global neonatal phototherapy devices market is expected to reach US$ 147.9 Mn by 2032.
• North America will account for 40.2% market share in 2025, driven by advanced NICU infrastructure.
• Phototherapy lamps dominate with 48.6% share in 2025, widely used across hospitals and NICUs.
• Neonatal jaundice management accounts for 83.2% share in 2025, owing to its high global prevalence.
• Portable and home-use devices are gaining traction due to decentralized healthcare needs.
• LED phototherapy devices are set to hold 62.1% market share by 2025 for their energy efficiency.
Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35192
Market Segmentation:
The market is segmented by product type, light source, and application. Phototherapy lamps, accounting for nearly half of the total share, remain the preferred solution in clinical settings due to their high-intensity light and ability to reduce bilirubin levels quickly. Alongside lamps, innovative hybrid incubator-phototherapy systems are gaining adoption as they combine thermal regulation with effective jaundice management, improving overall neonatal outcomes.
Based on application, neonatal jaundice management is by far the leading segment with over 83% share in 2025. Nearly 60% of full-term and 80% of preterm infants develop jaundice, creating consistent demand for reliable phototherapy devices. Other applications such as neonatal skin disease management, including treatments for infantile hemangiomas and eczema, are expected to expand gradually, backed by ongoing research in phototherapy solutions.
Regional Insights:
North America is expected to maintain its dominance with a 40.2% share by 2025, driven by its robust neonatal care infrastructure, high awareness among healthcare providers, and early adoption of LED-based technologies. Strategic collaborations, such as NeoLight’s partnerships in the U.S., further strengthen the region’s leadership.
East Asia, holding 18.3% share in 2025, is witnessing rapid growth due to healthcare advancements, technological innovation, and rising availability of affordable phototherapy solutions. Japan’s development of wearable jaundice monitoring devices and GE Healthcare’s digital expansion in Asia Pacific further boost accessibility and adoption.
Market Drivers:
The increasing incidence of neonatal jaundice is the primary growth driver, particularly among preterm and low-birth-weight infants. Transitioning from fluorescent to LED phototherapy devices has significantly improved treatment outcomes by ensuring higher efficiency, reduced heat output, and better energy savings. Additionally, rising government initiatives and NGO-led healthcare programs are enhancing accessibility to neonatal care in emerging economies, driving greater market adoption.
Market Restraints
A key challenge for the market lies in limited access to neonatal care in underdeveloped and rural regions. Many low-resource areas lack well-equipped NICUs and trained professionals to manage neonatal jaundice effectively. Awareness about early intervention remains low, leading to delayed treatments and higher risks of complications such as kernicterus. Affordability issues and supply chain gaps also limit the penetration of advanced devices in these regions.
Market Opportunities
Government investments in neonatal healthcare infrastructure present a significant opportunity for growth. High-birth-rate countries such as India and Brazil are expanding NICU facilities, training healthcare staff, and partnering with technology providers to improve neonatal outcomes. These initiatives are creating fertile ground for phototherapy device adoption. Additionally, the growing demand for portable, wearable, and AI-integrated phototherapy devices opens new avenues for manufacturers targeting decentralized healthcare delivery.
Reasons to Buy the Report:
• Gain in-depth insights into global and regional market dynamics driving neonatal phototherapy device adoption.
• Identify high-growth segments, such as LED-based and portable phototherapy systems.
• Understand competitive strategies of leading players, including mergers, acquisitions, and partnerships.
• Assess government and NGO-driven initiatives shaping neonatal healthcare infrastructure.
• Access market forecasts up to 2032 with detailed segment-wise analysis for strategic planning.
Frequently Asked Questions (FAQs):
• How Big is the Neonatal Phototherapy Devices Market?
• Who are the Key Players in the Global Market for Neonatal Phototherapy Devices?
• What is the Projected Growth Rate of the Neonatal Phototherapy Devices Market?
• What is the Market Forecast for Neonatal Phototherapy Devices for 2032?
• Which Region is Estimated to Dominate the Industry through the Forecast Period?
Company Insights
The neonatal phototherapy devices market is competitive, with several global and regional players innovating to expand their market presence. Key players include:
• GE HealthCare
• Natus Medical Incorporated
• KAY & COMPANY
• Medinain
• Phoenix Medical Systems
• Drägerwerk AG & Co. KGaA
• NOVOS
• Nareena Lifesciences Private Limited
• Atom Medical Corp
• Weyer GmbH
• Fanem
• Olidef Medical
• MTTS
• Advanced Instrumentations
• Ibis Medical
• Zhengzhou Dison Instrument and Meter Co., Ltd
• nice Neotech Medical Systems Pvt. Ltd.
• Alfamedic
• Heal Force Bio-Meditech Holdings Limited
• DAVID
• PediaCare Medical
Recent Developments
In November 2024, NeoLight entered a breakthrough technology group purchasing agreement with Premier, Inc. through its KIINDO™ pediatric group, enhancing accessibility of its Skylife Neonatal Phototherapy System.
In July 2024, NeoLight announced an exclusive U.S. distribution agreement with ANT Neuro for its nëo CFM (Cerebral Function Monitor), further strengthening its neonatal care portfolio.
Conclusion:
The neonatal phototherapy devices market is poised for steady growth as healthcare systems worldwide continue to prioritize advanced neonatal care. Rising incidences of neonatal jaundice, coupled with increasing preterm birth rates, highlight the urgent need for effective phototherapy solutions. As Persistence Market Research emphasizes, innovations in LED technology, hybrid incubator systems, and portable devices are reshaping treatment approaches, ensuring both clinical efficiency and broader accessibility.
While challenges such as limited access to modern neonatal care facilities in low-resource settings remain, ongoing government investments and NGO-led initiatives are bridging gaps in infrastructure and awareness. With North America leading the global market and Asia Pacific showing immense growth potential, manufacturers and healthcare providers have opportunities to expand their reach and innovate for cost-effective, patient-friendly solutions.
Read Related Reports:
